Under the Medicare Drug Price Negotiation Program, the HHS secretary negotiates directly with manufacturers on the prices ...

The U.S. Centers for Medicare and Medicaid Services (CMS) said on Monday that it would announce a list of 15 drugs eligible ...

The Trump administration is already gearing up for another round of Medicare drug price negotiations, while OpenAI launched a ...

Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is ...

CMS draft expands drug price talks to include Medicare Part B drugs and outlines steps for future renegotiations; public ...

The third cycle of the drug price negotiations will involve drugs under Medicare Part B. New prices are set to take effect in ...

From sweeping drug price reforms to proposed staffing mandates and changes to Medicaid financing, here are five federal policy moves from the last week that ASCs need to know: CMS proposes updates for ...

he would work with Congress to strengthen Medicare drug price negotiations, not just sign a piece of paper," he said. Trump knows “his executive order will be thrown out by the courts," added Sen.

CMS proposed several changes for the third round of Medicare drug price negotiations, including the potential inclusion of some drugs under Medicare Part B, in a draft guidance published May 12. The ...

President Trump recently signed a wide-ranging executive order urging Congress to amend a crucial provision of a Biden-era ...

President Donald Trump said his executive order on drug prices would lower some prices in half or more. But the details are ...

CMS said on Monday that it would announce a list of 15 drugs eligible for a third round of Medicare price negotiations by early February next year. For the first time, the list would include drugs ...